Status:
COMPLETED
Hybrid PET/CT in Cancer Patients
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of the present study is to assess the role of hybrid PET/CT imaging diagnosis of active malignancy in cancer patients with rising tumor markers after treatment and in the diagnosis of prim...
Eligibility Criteria
Inclusion
- Cancer patients in complete remission after treatment, with serial elevation of serum tumor markers and negative CT or other conventional imaging test.
- Patients with newly diagnosed metastatic cancer with unknown primary tumor
- Glucose levels below 150-200
- Patient signed informed consent
Exclusion
- Pregnant or lactating women
- Patient unable or not willing to tolerate the test until its completion
- One or more of the inclusion criteria is not fulfilled
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00396916
Start Date
December 1 2004
Last Update
April 11 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel